Prenatal morphine exposure induces age-related changes in seizure susceptibility in male rats

Pharmacology Biochemistry and Behavior

Volumn 60, Issue 3, 1998, Pages 635-638

  Vathy, Ilona ^a   Velíšková, Jana ^a   Moshé, Solomon L ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Development; Prenatal morphine; Seizure susceptibility

Indexed keywords

MORPHINE;

AGE; ANIMAL MODEL; ARTICLE; CLONIC SEIZURE; DRUG EFFECT; FEMALE; GESTATIONAL AGE; GONADECTOMY; MALE; NONHUMAN; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RAT; SEIZURE SUSCEPTIBILITY; TONIC CLONIC SEIZURE;

AGING; ANALGESICS, OPIOID; ANIMALS; EPILEPSY, TONIC-CLONIC; FEMALE; MALE; MORPHINE; ORCHIECTOMY; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, SPRAGUE-DAWLEY; SEIZURES; TESTOSTERONE;

EID: 0344352472     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(98)00048-3     Document Type: Article

References (41)

1. Adler, M. W.; Lin, C.-H.; Keinath, S. H.; Braverman, S.; Geller, E. B.: Anticonvulsant action of acute morphine administration in the rat. J. Pharmacol. Exp. Ther. 198:655-660; 1976.
2. Albertson, T. E.; Joy, R. M.; Stark, L. G.: Modification of kindled amygdaloid seizures by opiate agonists and antagonists. J. Pharmacol. Exp. Ther. 228:620-627; 1984.
3. Bohme, G. A.; Stutzmann, J. M.; Roques, B. P.; Blanchart, J. C.: Effects of selective mu- and delta-opioid peptides on kindled amygdaloid seizures in the rats. Neurosci. Lett. 74:227-231; 1987.
4. Browning, R. A.; Turner, F. J.; Simonton, R. L.; Bundman, M. C.: Effects of midbrain and pontine tegmental lesion on the maximal electroshock seizure pattern in rats. Epilepsia 22:583-594; 1981.
5. Browning, R. A.; Simonton, R. L.; Turner, F. J.: Antagonism of experimentally induced tonic seizures following a lesion in the midbrain tegmentum. Epilepsia 22:595-601; 1981.
6. Browning, R. A.: Role of the brain-stem reticular formation in tonic-clonic seizures: Lesion and pharmacological studies. Fed. Proc. 44:2425-2431; 1985.
7. Cain, D. P.; Corcoran, M. E.: Intracerebral beta-endorphin, metenkephalin and morphine: Kindling of seizures and handling-induced potentiation of epileptiform effects. Life Sci. 34:2535-2542; 1984.
8. Clendeninn, N.; Petraits, M.; Simon, E. J.: Ontological development of opiate receptors in rodent brain. Brain. Res. 118:157-160; 1976.
9. Cowan, A.; Geller, E. B.; Adler, M. W.: Classification of opioids on the basis of change in seizure threshold in rats. Science 206:465-467; 1979.
10. Cowan, A.; Tortella, F. C.; Adler, M. W.: A comparison of the anticonvulsant effects of two systemically active enkephalin analogues in rats. Eur. J. Pharmacol. 1971:117-121; 1981.
11. Fisher, W.; Bodewei, R.; VonVoigtlander, P. F.; Muller, M.: Anti-convulsant and related effects of U-54494A in various seizure tests. J. Pharmacol. Exp. Ther. 267:163-170; 1993.
12. Frenk, H.: Pro- and anticonvulsant actions of morphine and endogenous opioids: Involvement and interactions of multiple opiate and nonopiate systems. Brain Res. Rev. 6:197-210; 1983.
13. Frenk, H.; Engel, J. J.; Ackermann, R. F.: Endogenous opioids may mediate postictal behavioral depression in amygdaloid-kindled rats. Brain Res. 167:435-440; 1979.
14. Frey, H.-H.: Anticonvulsant effect of morphine and morphine-like analgesics in mongolian gerbils. Pharmacology 32:335-339; 1986.
15. 2+ changes during epileptiform discharges in the immature rat neocortex. Brain Res. 433:299-303; 1987.
16. Hauser, W. A.; Kurland, L. T.: The epidemiology of epilepsy in Rochester, MN 1935-1967. Epilepsia 16:1-66; 1975.
17. Jackson, H. C.; Nutt, D. J.: Investigation of the different types of opioid receptor involved in electroconvulsive shock-induced antinociception and catalepsy in the rat. J. Pharm. Pharmacol. 43:640-643; 1991.
18. Jones, L. S.: Naloxone blocks antiepileptogenic properties of an in vitro electroconvulsive shock model. Brain Res. 564:336-340; 1991.
19. Kellogg, C. K.: Benzodiazepines and the developing nervous system: Laboratory findings and clinical implications. In: Zagon, I. S.; Slotkin, T. A., eds. Maternal substance abuse and the developing nervous system. San Diego: Academic Press; 1992:283-321.
20. A receptor binding. Pharmacol. Biochem. Behavior. 43:441-447; 1992.
21. Lee, V. W. K.; de Kretser, D. M.; Hudson, B.; Wang, C.: Variations in serum FSH, LH and testosterone levels in male rats from birth to sexual maturity. J. Reprod. Fertil. 42:121-126; 1975.
22. Moshé, S.; Shinnar, S.; Swann, J.: Partial (focal) seizures in developing brain. In: Schwarzkroin, P.; Moshé, S.; Noebels, J.; Swann, J., eds. Brain development and epilepsy. New York: Oxford University Press; 1995:34-65.
23. Moshé, S. L.; Albala, B. J.: Maturational changes in postictal refractoriness and seizure susceptibility in developing rats. Ann. Neurol. 13:552-557; 1983.
24. Przewlocka, B.; Lason, W.; Machelska, H.; van Luijtelaar, G.; Coenen, A.; Przewlocki, R.: Kappa opioid receptor agonists suppress absence seizures in WAG/Rij rats. Neurosci. Lett. 186:131-134; 1995.
25. Rimanóczy, A.; Vathy, I.: Prenatal exposure to morphine alters brain μ opioid receptor characteristics in rats. Brain Res. 690:245-248; 1995.
26. Rocha, L.; Engel, J. J.; Ackermann, R. F.: Effects of chronic naloxone pretreatment on amygdaloid kindling in rats. Epilepsy Res. 10:103-110; 1991.
27. Schwartzkroin, P. A.: Epileptogenesis in the immature CNS. In: Schwartzkroin, P. A.; Wheal, H. V., eds. Electrophysiology of epilepsy. London: Academic Press; 1984:389-412.
28. Sircar, R.; Velíšková, J.; Moshé, S. L.: Chronic neonatal phencyclidine treatment produces age-related changes in pentylenetetrazol-induced seizures. Dev. Brain Res. 81:185-191; 1995.
29. 35S] Methionine. Brain Res. 358:241-248; 1985.
30. Thomas, J.: Gender difference in susceptibility to picrotoxin-induced seizuresis seizure- and stimulation-dependent. Brain Res. Bull. 24:7-10; 1990.
31. Tortella, F. C.; Echevarria, E.; Robles, L.; Mosberg, H. I.; Holaday, J. W.: Anticonvulsant effects of mu (DAGO) and delta (DPDPE) enkephalins in rats. Peptides 9(5):1177-1181; 1988.
32. Vathy, I.; Etgen, A. M.; Barfield, R. J.: Effects of prenatal exposure to morphine on the development of sexual behavior in rats. Pharmacol. Biochem. Behav. 22:227-232; 1985.
33. Vathy, I.; Kátay, L.: Effects of prenatal morphine on adult sexual behavior and brain catecholamines in rats. Dev. Brain Res. 73:115-122; 1992.
34. Vathy, I.; Rimanóczy, A.; Eaton, R. C.; Kátay, L.: Modulation of catecholamine turnover rate in brain regions of rats exposed prenatally to morphine. Brain Res. 662:209-215; 1994.
35. Velíšková, L.; Kubová, H.; Pohl, M.; Stanková, L.; Mareš, P.; Schickerová, R.: Pentylenetetrazol-induced seizures in rats: An onto-genetic study. Naunyn Schmiedebergs Arch. Pharmacol. 346:588-591; 1992.
36. Velíšek, L.; Mareš, P.: Differential effects of naloxone on postictal depression. Epilepsy Res. 12:37-43; 1992.
37. Velíšek, L.; Velíšková, J.; Ptachewich, Y.; Ortíz, J.; Shinnar, S.; Moshé, S. L.: Age-dependent effects of GABA agents on flurothyl seizures. Epilepsia 36:636-643; 1995.
38. Vito, C. C.; Fox, T. O.: Embryonic rodent brain contains estrogen receptors. Science 204:517-519; 1979.
39. Vito, C. C.; Fox, T. O.: Androgen and estrogen receptors in embryonic and neonatal rat brain. Dev. Brain Res. 2:97-100; 1981.
40. Vito, C. C.; Wieland, S. J.; Fox, T. O.: Androgen receptors exist throughout the "critical period" of brain sexual differentiation. Nature 282:308-310; 1979.
41. Zagon, T. S.; McLaughlin, P. J.: Maternal exposure to opioids and the developing nervous system; laboratory findings. In: Zagon, I. S.; Slotkin, T. A., eds. Maternal substance abuse and the developing nervous system. San Diego: Academic Press; 1992:241-282.